Further examination on preoperative GBM samples found a distinct difference between the original tumour and the recurrence based on MMP-9 levels of serum sEVs (Figure 2e), and the recurrence showed a lower level of MMP-9 on average (p < 0.0001). Here, MMP9 is linked to glioblastoma.